Literature DB >> 3073547

New cardiotonic agents--a promising approach for treatment of heart failure.

B Wetzel, N Hauel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3073547     DOI： 10.1016/0165-6147(88)90031-4

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  7 in total

Review 1.  Cardiovascular drugs.

Authors:  P Vermeij
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

2.  The 'calcium sensitising' effects of ORG30029 in saponin- or Triton-skinned rat cardiac muscle.

Authors:  D J Miller; D S Steele
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

Review 3.  Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapy.

Authors:  D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

4.  Potentiation by cyclic GMP of beta-adrenergic effect on Ca2+ current in guinea-pig ventricular cells.

Authors:  K Ono; W Trautwein
Journal:  J Physiol       Date:  1991-11       Impact factor: 5.182

Review 5.  Phosphodiesterase inhibition by new cardiotonic agents: mechanism of action and possible clinical relevance in the therapy of congestive heart failure.

Authors:  H von der Leyen
Journal:  Klin Wochenschr       Date:  1989-06-15

6.  The effects of reported Ca2+ sensitisers on the rates of Ca2+ release from cardiac troponin C and the troponin-tropomyosin complex.

Authors:  S J Smith; P J England
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

7.  The effects of caffeine and Ca2+ on rigor tension in triton-treated rat ventricular trabeculae.

Authors:  D S Steele; G L Smith
Journal:  Pflugers Arch       Date:  1992-07       Impact factor: 3.657
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.